Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Charles Messerly
Institution:
Medical College of Wisconsin
Observed institution:
Medical College of Wisconsin
ORCID:
0009-0006-0631-4694
Observed ORCID:
0009-0006-0631-4694
OpenAlex ID:
A5093865488
Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
2026
·
Daniel Dorbin
, Juliannie Herrera
, et al.
·
Cancer Research
·
4
PDF
Figure S2 from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
2026
·
Daniel Dorbin
, Juliannie Herrera
, et al.
Figure S4 from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
2026
·
Daniel Dorbin
, Juliannie Herrera
, et al.
Figure S1 from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
2026
·
Daniel Dorbin
, Juliannie Herrera
, et al.
Data from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
2026
·
Daniel Dorbin
, Juliannie Herrera
, et al.
Figure S6 from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
2026
·
Daniel Dorbin
, Juliannie Herrera
, et al.
Figure S3 from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
2026
·
Daniel Dorbin
, Juliannie Herrera
, et al.
Figure S5 from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
2026
·
Daniel Dorbin
, Juliannie Herrera
, et al.
Complications of Anorexia Nervosa
2024
·
Rami M. El-Baba
, Charles Messerly
, et al.
·
Applied Radiology
Show more works
View as search
Works count:
9
Citation count:
4
H-index:
1
I10-index:
Year
Topic
Type